Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000906304-25-000129
Filing Date
2025-07-16
Accepted
2025-07-16 11:35:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8268
  Complete submission text file 0000906304-25-000129.txt   10229
Mailing Address ONE MADISON AVENUE NEW YORK NY 10010
Business Address ONE MADISON AVENUE NEW YORK NY 10010 212-508-4500
ROYCE & ASSOCIATES LP (Filed by) CIK: 0000906304 (see all company filings)

EIN.: 522343049 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SCHEDULE 13G/A

Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Subject) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-85653 | Film No.: 251126617
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)